(02) 4474 2200 Moruya Medical Centre, 73A Queen Street, Moruya NSW 2537
Your Privacy Is Our Business
An ethical & confidentiality code,in line with
the Australian Medical Association Code of
Ethics & the Privacy Act is upheld by all staff.
Moruya District Hospital - 4474 2666 GP Health line - 1800 022 222
Monday to Friday - 8.00am to 5.00pm Closed - Weekends and Public Holidays
Due to the ongoing COVID cases and to keep us all as safe as possible, the practice policy continues to require all symptomatic patients (fever, cough, sore throat or shortness of breath) to produce a negative COVID swab before being seen in the surgery. We will NOT be accepting at-home rapid tests. The negative swab results must be shown to reception staff
Additionally, whilst restrictions begin to ease, we still require mandatory mask wearing in the waiting/consultation rooms.
Moruya Medical Centre continues to participate in the Australian Governments COVID-19 vaccination roll out and will commence Pfizer booster doses from January 2022.
Right now you are eligible for a booster if:
On Friday 25 March, the Federal Minister for Health and Aged Care, Greg Hunt, confirmed a fourth dose of a COVID-19 vaccine is now recommended four months after an initial booster dose for the following groups:
* All over-65s
* All residents of aged and disability care facilities, regardless of age
* Those aged 16 and above with severe immunocompromise
* Aboriginal and Torres Strait Islander people aged 50 and older
For people in those categories who had a confirmed COVID-19 infection after receiving a first booster dose, the follow-up booster is recommended with a gap of four months after infection.
Booster doses are not mandatory, however they are recommended to maintain immunity against COVID-19.
Please ring the surgery to book your appointment.
ATAGI is not currently recommending booster doses for:
people aged 12 to 15 years
Read ATAGI’s advice on COVID-19 booster doses.
The Australian Government will provide COVID-19 vaccines to children aged 5 to 11 years through the COVID-19 Vaccination Program
• This means that anyone in Australia aged 5 to 11 years can receive a COVID-19 vaccine.
• Pfizer is the only vaccine that has been approved for use in this age group.
• The primary course is two doses, with an interval of 8-weeks. The interval can be shorted to a minimum of 3 weeks in special circumstances.
• The roll-out to this age group will commence from 10 January 2022.
